Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?

One of the researchers described the circumstances that led to the discovery as “serendipity.” This year’s prestigious Lasker ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

As Novo Nordisk A/S and Eli Lilly and Co. go head-to-head in the U.S. and Chinese glucagon-like peptide-1 receptor agonists ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and ...

Chinese pharmaceutical and biotech companies are leading development of glucagon-like peptide-1 receptor agonists as Novo Nordisk A/S and Eli Lilly and Co. edge closer to launching blockbuster ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for type 2 diabetes and ...

GLP-1RA vs insulin use was associated with improved cardiovascular and kidney outcomes among patients with type 2 diabetes on dialysis.

If you were prescribed a GLP-1, it's important that you understand how your insurance coverage works in order to stay on top ...

to examine potential applications of glucagon-like peptide-1 receptor (GLP-1R) agonists in central nervous system disorders, such as dementia, Parkinson’s disease, substance and alcohol use disorders, ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...